Recombinant Human ACY3 Protein，His

ACY3, or Arylsulfatase C, is an important enzyme involved in the hydrolysis of aryl sulfate compounds, playing a crucial role in various biological processes, including the metabolism of steroid hormones and the regulation of sulfate levels in tissues. Research on ACY3 recombinant protein has gained significance due to its potential applications in understanding inherited metabolic disorders, particularly those associated with sulfate metabolism. Mutations in the ACY3 gene can lead to severe neurological and metabolic disorders, prompting scientists to explore the structural and functional properties of ACY3 to elucidate its mechanisms of action. Additionally, the production of recombinant ACY3 provides a valuable tool for studying enzyme kinetics, substrate specificity, and the effects of potential inhibitors, thereby contributing to the development of therapeutic strategies aimed at addressing ACY3-related diseases. Detailed characterization of this protein through biochemical assays and structural biology techniques enhances our understanding of its role in human health and disease. Furthermore, the therapeutic potential of ACY3 as a target for drug development makes it a significant focus of research, especially in the context of personalized medicine, where specific metabolic pathways can be modulated to offer tailored treatments for affected individuals. As research progresses, the insights gained from recombinant ACY3 studies are expected to pave the way for innovative approaches in diagnostics and therapies for metabolic disorders linked to this enzyme.